Intralesional Rituximab for the Treatment of Conjunctival Indolent Lymphoma (IRIS)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2012 by IRCCS San Raffaele.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Andres J. M. Ferreri, IRCCS San Raffaele Identifier:
First received: January 6, 2012
Last updated: January 17, 2012
Last verified: January 2012
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2015
  Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)